Home / Industries / Life Sciences
Life Sciences & Pharma
Regulated evidence, ready for AI.
GroundTrue Health modernizes regulated evidence data and makes it ready for AI, once: safety, clinical, real-world and commercial data, certified and traceable, so every AI use case reuses it without putting validation or compliance at risk.
The industry challenge
The evidence exists. It isn't yet usable together.
- 01
Evidence in silos
Each kind of evidence lives in its own system, with its own owners.
- 02
Regulated meaning that drifts
“Serious” and “signal” mean different things by function.
- 03
Validation slows every change
Each pipeline change becomes a validation exercise.
- 04
Real-world data without provenance
Untraceable cohorts will not support a submission.
- 05
AI that cannot pass inspection
Models without provenance stall at quality assurance.
GroundTrue Health for life sciences
One foundation for regulated evidence. Safety, evidence and commercial on top.
Don’t build another validated pipeline for every use case. Certify the evidence once, define regulated meaning once, and let each use case reuse it, inside GxP and Part 11 controls.
The governed life-sciences data foundation
Your sourcesRegulated evidence
Adverse-event casesLiteratureClaims and EHR cohortsRegistry and lab dataSite history and protocolsPrescription and CRM data
Data foundationCertified, traceable records
Case recordsLinked, de-identified patient journeysOne governed account and HCP view
AI readinessRegulated definitions, agreed once
“Serious” and “signal” defined onceCohort definitionsVersioned, with provenance
Analytics & AIAI that can pass inspection
Signal detectionEnrollment forecastsNext-best engagementHuman in the loop
ApplicationsSafety, evidence, commercial
Drug safety signals · builtReal-world evidenceTrial site selectionHCP engagement
Drug safety signal intelligence is built. Real-world evidence, trial site selection and HCP engagement are in progress on the same foundation. How we build it →
Use cases
Where the foundation pays back first.
Can our real-world data stand up to regulators and payers?
Real-World Evidence Foundation
Linked, de-identified data with provenance for every record.
- DataClaims, EHR, registry and lab data
- IntelligenceLinked, de-identified patient journeys
- ActionStudies run on governed data
- AimFaster, more defensible evidence
Which sites will actually recruit this patient population, and when?
Trial Site Selection & Enrollment
- DataSite history, protocol criteria and real-world data
- IntelligenceSite rankings and enrollment forecasts
- ActionActivation focused on likely recruiters
- AimFewer under-enrolling sites, shorter timelines
Which physicians should we reach, through which channel, with what message?
Commercial Analytics & HCP Engagement
One governed account and HCP view, within compliance rules.
- DataPrescription, claims, CRM and field data
- IntelligenceHCP segments and next-best engagement
- ActionField and omnichannel plans on one view
- AimHigher return on commercial spend
Built use case
Drug safety signal intelligence, end to end.
A working solution built on the foundation. Details are shared in conversation.
What it moves
- Intake effort per ICSR
- Time from first report to validated signal
- Duplicates reaching assessment
- Late expedited cases
Who decides
- Named owners for every safety decision, starting with the QPPV office
Governance & compliance
Inspection-ready by design.
In life sciences, governance is what lets AI into production. It is built into the architecture from the first sprint.
- GxP-validated zonesValidated and exploratory work kept apart.
- Part 11 audit trailsEvery record, decision and model version attributable.
- Pharmacovigilance rulesSignal management built into the workflow, not bolted on.
- Privacy by designDe-identified data, under HIPAA and GDPR.
- Human in the loopAI suggests, qualified reviewers decide: no automated submission.
Working on safety, evidence or commercial data?
In 30 minutes with a principal, we'll talk through your data, your constraints and where AI can safely pay back first.
What happens next
- No pitch deck.
- A focused discussion of your problem.
- A written view of where to start.